Presentation is loading. Please wait.

Presentation is loading. Please wait.

Updates From the International AIDS Conference (IAS 2019)

Published byHedvig Torp Modified over 5 years ago

Similar presentations

Presentation on theme: "Updates From the International AIDS Conference (IAS 2019)"— Presentation transcript:

1 Updates From the International AIDS Conference (IAS 2019)

2 Updates From the International AIDS Conference (IAS 2019)

3

4 CME Information

5 Nursing and Pharmacy Credits

6 Evaluations will be available in your IAS-USA “My Activities” page by 5 pm PT today. See the IAS–USA website for instructions on claiming CME, pharmacy, nursing, or pharmacotherapy credits, or a certificate of participation.

7 Grant Support for this Webinar

8 Navigating the Webinar

9 Poll 1

10 Poll 2

11 Poll 3

12 Updates From the International AIDS Conference (IAS 2019)

13 Financial Relationships With Commercial Entities

14 Learning Objectives

15 Pretest Question 1

16 Pretest Question 2

17 HIV/AIDS Epidemiology

18 WHO 2019 Annual Report

19 WHO 2019 Annual Report

20 WHO 2019 Annual Report

21 WHO 2019 Annual Report

22 WHO 2019 Annual Report

23 IAS 2019

24 ART – Initial Therapy

25 ADVANCE

26 ADVANCE: Weight Gain

27 GEMINI: Initial ART with DTG/3TC

28 REFLATE: Initial ART with TB

29 TSEPAMO: DTG + Neural Tube Defects (NTD)

30 DTG + Neural Tube Defects (NTD): Additional Data

31 WHO: Updated ART Recommendations (7/22/19)

32 ART -- Switch/Maintenance

33 Study : Switch

34 ART Switch in Women

35 TANGO: Switch to DTG/3TC

36 DUALIS: Switch to DTG + Boosted DRV

37 CAB+RPV IM: ATLAS and FLAIR Pooled Analysis (1)

38 CAB+RPV IM: ATLAS and FLAIR Pooled Analysis (2)

39 CAB+RPV IM: ATLAS and FLAIR Pooled Analysis (3)

40

41 QUATUOR (ANRS 170)

42 ART -- New Drugs

43 Islatravir (ISL; MK-8591; EFdA)

44 Islatravir (MK-8591; EFdA)

45 Islatravir (MK-8591; EFdA)

46 Islatravir (MK-8591; EFdA)

47 Islatravir (MK-8591; EFdA)

48 Islatravir (MK-8591; EFdA)

49

50 Fostemsavir (FTR): Oral HIV Attachment Inhibitor

51 Fostemsavir (FTR): Oral Attachment Inhibitor

52 HIV Capsid Inhibitors

53 Capsid Inhibitor: GS-6207

54 Capsid Inhibitor: GS-6207

55 Capsid Inhibitor: GS-6207

56 ART -- Prevention

57 On-Demand PrEP: Prevenir INTERIM REPORT

58 DISCOVER: PrEP with TAF/FTC vs. TDF/FTC

59 Islatravir Implant

60 Islatravir Implant

61 Islatravir Implant

62 HIV Vaccine Study: ASCENT (HPX2003/HVTN 118)

63 HIV Vaccine Study: ASCENT (HPX2003/HVTN 118)

64 HIV Vaccine Study: Next Steps

65 Acknowledgments

66 Posttest Question 1

67 Posttest Question 2

68 Question-and-Answer

69

70 Evaluations will be available in your IAS-USA “My Activities” page by 5 pm PT today. See the IAS–USA website for instructions on claiming CME, pharmacy, nursing, or pharmacotherapy credits, or a certificate of participation.

71 Final Poll

72

73 Thank You

Download ppt "Updates From the International AIDS Conference (IAS 2019)"

Similar presentations

Update: National AIDS Programmes FHI, Horizons, HHS-CDC & HRSA, Macro, Measure, Synergy, USAID, WHO,UNAIDS Katherine Marconi, Ph.D., MS Presenter A Guide.

Update: National AIDS Programmes FHI, Horizons, HHS-CDC & HRSA, Macro, Measure, Synergy, USAID, WHO,UNAIDS Katherine Marconi, Ph.D., MS Presenter A Guide.
Monitoring and Evaluation: A Review of Terms. Goals To provide better treatment for people with tuberculosis in Country X To achieve a treatment success.

Monitoring and Evaluation: A Review of Terms. Goals To provide better treatment for people with tuberculosis in Country X To achieve a treatment success.
IAS 2012 feedback: www.i-Base.info UK Consortium: September 2012 IAS 2012 Feedback: New findings, better drugs and the goal of a cure Simon Collins HIV.

IAS 2012 feedback: UK Consortium: September 2012 IAS 2012 Feedback: New findings, better drugs and the goal of a cure Simon Collins HIV.
DR CHIDI V NWENEKA EXECUTIVE DIRECTOR AFRICAN AIDS VACCINE PARTNERSHIP AAVP and the Promotion of HIV Vaccines in Africa: Supporting Career Development.

DR CHIDI V NWENEKA EXECUTIVE DIRECTOR AFRICAN AIDS VACCINE PARTNERSHIP AAVP and the Promotion of HIV Vaccines in Africa: Supporting Career Development.
I have no relevant financial relationships with the manufacturers of any commercial products and/or provider of commercial services discussed in this CME.

I have no relevant financial relationships with the manufacturers of any commercial products and/or provider of commercial services discussed in this CME.
Interamerican College of Physicians and Surgeons.

Interamerican College of Physicians and Surgeons.
Antiretroviral Treatment Monitoring: A Canadian Case Example Antiretroviral Treatment Monitoring: A Canadian Case Example Robert Hogg, PhD BC Centre for.

Antiretroviral Treatment Monitoring: A Canadian Case Example Antiretroviral Treatment Monitoring: A Canadian Case Example Robert Hogg, PhD BC Centre for.
Title of Presentation Speaker Names, Credentials, Full Title Collaborative Family Healthcare Association 17 th Annual Conference October 15-17, 2015 Portland,

Title of Presentation Speaker Names, Credentials, Full Title Collaborative Family Healthcare Association 17 th Annual Conference October 15-17, 2015 Portland,
ART: When to Start? – Case Discussion Roy M. Gulick, MD, MPH Professor of Medicine Chief, Division of Infectious Diseases Weill Medical College of Cornell.

ART: When to Start? – Case Discussion Roy M. Gulick, MD, MPH Professor of Medicine Chief, Division of Infectious Diseases Weill Medical College of Cornell.
Submitting assignments to TURNITIN.COM You need to login and create an account at www.turnitin.com using the following info: Class ID---1320036 Password---v5micro05.

Submitting assignments to TURNITIN.COM You need to login and create an account at using the following info: Class ID Password---v5micro05.
Calculating Postsecondary Costs 6 th Grade Postsecondary Costs #4.

Calculating Postsecondary Costs 6 th Grade Postsecondary Costs #4.
Diagnostics - More than 100 years old Drugs – Last drug 40 years old Vaccine – Nearly 90 years old Lucica Ditiu Executive Secretary, Stop TB Partnership.

Diagnostics - More than 100 years old Drugs – Last drug 40 years old Vaccine – Nearly 90 years old Lucica Ditiu Executive Secretary, Stop TB Partnership.
Oklahoma Nurses Association is an approved provider of continuing nursing education by the Texas Nurses Association, an accredited approver by the American.

Oklahoma Nurses Association is an approved provider of continuing nursing education by the Texas Nurses Association, an accredited approver by the American.
Appropriate Evaluation & Treatment of UTI in the Elderly Final Workshop June 17, 2014.

Appropriate Evaluation & Treatment of UTI in the Elderly Final Workshop June 17, 2014.
Speaker Disclosure Explanation

Speaker Disclosure Explanation
Title of Presentation Speaker Names, Credentials, Full Title Collaborative Family Healthcare Association 13 th Annual Conference October 27-29, 2011 Philadelphia,

Title of Presentation Speaker Names, Credentials, Full Title Collaborative Family Healthcare Association 13 th Annual Conference October 27-29, 2011 Philadelphia,
Following the Yellow Brick Road to the Emerald City of Patient Care Coordination On a Budget Cortney McDuff, RN Cindy McHenry, RN BSN.

Following the Yellow Brick Road to the Emerald City of Patient Care Coordination On a Budget Cortney McDuff, RN Cindy McHenry, RN BSN.
Understanding the Rationale of the 2015 WHO Guidelines on PrEP IAS Satellite Session Heather Watts M.D. Office of the Global AIDS Coordinator July 18,

Understanding the Rationale of the 2015 WHO Guidelines on PrEP IAS Satellite Session Heather Watts M.D. Office of the Global AIDS Coordinator July 18,
Thailand experience in implementing collaborative HIV/TB activities Anupong Chitwarakorn, MD Ministry of Public Health, Thailand TB/HIV Satellite symposium.

Thailand experience in implementing collaborative HIV/TB activities Anupong Chitwarakorn, MD Ministry of Public Health, Thailand TB/HIV Satellite symposium.
Harry Lampiris, MD, Moderator Chief, ID Section, Medical Service, SFVAMC Professor of Clinical Medicine, UCSF.

Harry Lampiris, MD, Moderator Chief, ID Section, Medical Service, SFVAMC Professor of Clinical Medicine, UCSF.

Similar presentations

Ads by Google